Second, mPRα can promote the development of lung adenocarcinoma and is a potential target for treatment, and finally that mPRα mediates the inhibitory effect of P4 on the PKA/CREB and PKA/β‐catenin signaling pathway to suppress the growth of lung adenocarcinoma cells. The gene discussed is CREB1; the disease is lung adenocarcinoma.